As detailed below, the return-on-investment results for this Moderna position was: +4.8% absolute return in 19 days (equivalent to a +92.5% annualized return-on-investment).
Moderna Inc. (MRNA) -- Covered Calls Position Closed 05/04/2022 Bought 200 Moderna shares @ $145.50
05/04/2022 Sold 2 MRNA May 20th, 2022 $140.00 Call options @ $12.32 per share.
05/20/2022 Two MRNA Call options expired out-of-the-money, so the 200 MRNA share remained in the Covered Calls Advisor Portfolio. The stock price was $136.25 at the options expiration last Friday.
05/23/2022 Closed out this Covered Calls position by selling 200 Moderna shares at $139.60
The overall performance results (including commissions) for this Moderna Covered Calls position was as follows:
Stock Purchase Cost: $26,637.34
= ($145.50 - $12.32) *200 shares + $1.34 commission
Net Profit:
(a) Options Income: +$2,462.66
= ($12.32 *200 shares) - $1.34 commission
(b) Dividend Income: +$0.00
(c) Capital Appreciation (MRNA shares sold on 5/23/2022 at $139.60 per share): -$1,180.00
+($139.60 - $145.50) * 200 shares
Total Net Profit (Moderna Covered Calls position closed out): +$1,282.66
= (+$2,462.66 options income +$0.00 dividend income -$1,180.00 capital appreciation)
Absolute Return-on-Investment: +4.8%
= +$1,282.66/$26,637.34
Annualized Return-on-Investment: +92.5%
= (+$1,282.66/$26,637.34) * (365/19 days)
